Skip to main content
Erschienen in: Pediatric Nephrology 6/2006

01.06.2006 | Original Article

Calcium and phosphate balance in adolescents on home nocturnal haemodialysis

verfasst von: Daljit K. Hothi, Elizabeth Harvey, Elizabeth Piva, Laura Keating, Donna Secker, Denis F. Geary

Erschienen in: Pediatric Nephrology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Studies in adults show superior serum phosphate and parathyroid hormone (PTH) control on slow nocturnal haemodialysis (NHD) compared with conventional haemodialysis. We studied the progress of four children aged 12, 13, 14 and 16 years after they had been initiated on NHD. The follow-up period ranged from 6 months to 20 months. Biochemical indices of bone metabolism were collected prospectively. All four children were initially dialysed against a 1.5 mmol/l calcium bath. In two patients, owing to biochemical hypocalcaemic episodes, the dialysate calcium concentration was increased to 1.75 mmol/l. One patient became hypercalcaemic and received calcitonin for bone pain secondary to osteoporosis and was dialysed against a 1.0 mmol/l calcium bath. Including an evaluation of dietary intake, all four patients had a net positive calcium balance, ranging from 5.1 mmol/m2 body surface area (BSA) per day to 24.3 mmol/m2 BSA per day. A significant reduction in the pre-dialysis phosphate level was observed in all four patients, such that none required dietary restrictions or phosphate binders, and dialysate phosphate supplements of 0.8–2.03 mmol/l were employed to prevent hypophosphataemia. The (Ca×PO4) dropped below 4.4 mmol2 l−2 in all four patients. Concurrently, significant reductions in intact PTH levels were seen in all four patients, but the level dropped to below normal range in two. In our cohort of patients, NHD rapidly lowered plasma phosphate and PTH levels, and additional dialysate phosphate and possibly calcium may be necessary to prevent bone demineralisation due to chronic losses and to prevent oversuppression of PTH.
Literatur
1.
Zurück zum Zitat Mathias R, Salusky IB, Harman WH, Paredes A, Emans J, Segre G, Goodman W (1993) Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children’s hospital. J Am Soc Nephrol 12:1938–1946 Mathias R, Salusky IB, Harman WH, Paredes A, Emans J, Segre G, Goodman W (1993) Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children’s hospital. J Am Soc Nephrol 12:1938–1946
2.
Zurück zum Zitat Spalding EM, Chamney PW, Farrington K (2002) Phosphate kinetics during haemodialysis: evidence for biphasic regulation. Kidney Int 61:655–667CrossRef Spalding EM, Chamney PW, Farrington K (2002) Phosphate kinetics during haemodialysis: evidence for biphasic regulation. Kidney Int 61:655–667CrossRef
3.
Zurück zum Zitat Fajardo L, Campistrús, Ríos P, Góomez T (2003) Evolution of serum phosphate in long intermittent haemodialysis. Kidney Int 63 [Suppl 85]:S66–S68CrossRef Fajardo L, Campistrús, Ríos P, Góomez T (2003) Evolution of serum phosphate in long intermittent haemodialysis. Kidney Int 63 [Suppl 85]:S66–S68CrossRef
4.
Zurück zum Zitat Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C (2003) Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42:24–29CrossRef Lindsay RM, Alhejaili F, Nesrallah G, Leitch R, Clement L, Heidenheim AP, Kortas C (2003) Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42:24–29CrossRef
5.
Zurück zum Zitat Al-Hejaili F, Kortas C, Leitch R, Heidenheim PA, Clement L, Nesrallah G, Lindsay RM (2003) Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14:2322–2328CrossRef Al-Hejaili F, Kortas C, Leitch R, Heidenheim PA, Clement L, Nesrallah G, Lindsay RM (2003) Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14:2322–2328CrossRef
6.
Zurück zum Zitat Pierratos A (2004) Daily nocturnal hemodialysis. Kidney Int 65:1975–1986CrossRef Pierratos A (2004) Daily nocturnal hemodialysis. Kidney Int 65:1975–1986CrossRef
7.
Zurück zum Zitat Geary DF, Piva E, Gajaria M, Tyrrel J, Picone G, Harvey E (2004) Development of a nocturnal home hemodialysis (NHHD) program for children. Semin Dial 17:115–117CrossRef Geary DF, Piva E, Gajaria M, Tyrrel J, Picone G, Harvey E (2004) Development of a nocturnal home hemodialysis (NHHD) program for children. Semin Dial 17:115–117CrossRef
8.
Zurück zum Zitat Simonsen O (2000) Slow nocturnal dialysis as a rescue treatment for children and young patients with end-stage renal failure. J Am Soc Nephrol 11:327A Simonsen O (2000) Slow nocturnal dialysis as a rescue treatment for children and young patients with end-stage renal failure. J Am Soc Nephrol 11:327A
9.
Zurück zum Zitat Geary DF, Piva E, Tyrrel J, Gajaria MJ, Picone G, Keating LE, Harvey EA (2005) Home nocturnal hemodialysis in children. J Pediatr 147:383–387CrossRef Geary DF, Piva E, Tyrrel J, Gajaria MJ, Picone G, Keating LE, Harvey EA (2005) Home nocturnal hemodialysis in children. J Pediatr 147:383–387CrossRef
10.
Zurück zum Zitat Fischbach M, Edefonti A, Schröder C, Watson A, The European Pediatric Dialysis Working Group (2005) Hemodialysis in children: general practical guidelines. Pediatr Nephrol 20:1054–1066CrossRef Fischbach M, Edefonti A, Schröder C, Watson A, The European Pediatric Dialysis Working Group (2005) Hemodialysis in children: general practical guidelines. Pediatr Nephrol 20:1054–1066CrossRef
11.
Zurück zum Zitat Fischbach M, Boudailliez B, Foulard M (1997) Phosphate end dialysis value: a misleading parameter of hemodialysis efficiency. Pediatr Nephrol 11:193–195CrossRef Fischbach M, Boudailliez B, Foulard M (1997) Phosphate end dialysis value: a misleading parameter of hemodialysis efficiency. Pediatr Nephrol 11:193–195CrossRef
12.
Zurück zum Zitat Pogglitsch H, Estelberger W, Petek W, Zitta S, Ziak E (1989) Relationship between generation and plasma concentration of inorganic phosphorous. In vivo studies in dialysis patients and in vitro studies on erythrocytes. Int J Artif Organs 12:524–532CrossRef Pogglitsch H, Estelberger W, Petek W, Zitta S, Ziak E (1989) Relationship between generation and plasma concentration of inorganic phosphorous. In vivo studies in dialysis patients and in vitro studies on erythrocytes. Int J Artif Organs 12:524–532CrossRef
13.
Zurück zum Zitat Fischbach M, Hamel G, Simeoni U, Geisert J (1992) Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate). Nephron 62:155–160CrossRef Fischbach M, Hamel G, Simeoni U, Geisert J (1992) Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate). Nephron 62:155–160CrossRef
14.
Zurück zum Zitat Bose S, French S, Evans FJ, Joubert F, Balaban RS (2003) Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem 278:39155–39165CrossRef Bose S, French S, Evans FJ, Joubert F, Balaban RS (2003) Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem 278:39155–39165CrossRef
15.
Zurück zum Zitat Lotz M, Zisman E, Bartter FC (1968) Evidence for phosphorus depletion syndrome in man. N Eng J Med 278:409–415CrossRef Lotz M, Zisman E, Bartter FC (1968) Evidence for phosphorus depletion syndrome in man. N Eng J Med 278:409–415CrossRef
16.
Zurück zum Zitat Anderson PT, Toft E, Hansen AK, Sinkjaer T (1991) Postoperative hypophosphataemia and muscle function. Br J Surg 78:114–116CrossRef Anderson PT, Toft E, Hansen AK, Sinkjaer T (1991) Postoperative hypophosphataemia and muscle function. Br J Surg 78:114–116CrossRef
17.
Zurück zum Zitat Hinken AC, McDonald KS (2004) Inorganic phosphate speeds loaded shortening in rat skinned cardiac myocytes. Am J Physiol Cell Physiol 287:C500–C507CrossRef Hinken AC, McDonald KS (2004) Inorganic phosphate speeds loaded shortening in rat skinned cardiac myocytes. Am J Physiol Cell Physiol 287:C500–C507CrossRef
18.
Zurück zum Zitat Salusky IB, Kuizon BG, Jüppner H (2004) Special aspects of renal osteodystrophy in children. Semin Nephrol 24:69–77CrossRef Salusky IB, Kuizon BG, Jüppner H (2004) Special aspects of renal osteodystrophy in children. Semin Nephrol 24:69–77CrossRef
19.
Zurück zum Zitat Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillan R, Fournier A (1991) Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516–524CrossRef Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillan R, Fournier A (1991) Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516–524CrossRef
20.
Zurück zum Zitat Qi Q, Monier-Faugere MC, Geng Z, Malluche HH (1995) Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622–631CrossRef Qi Q, Monier-Faugere MC, Geng Z, Malluche HH (1995) Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622–631CrossRef
21.
Zurück zum Zitat Waller S, Ridout D, Cantor T, Rees L (2005) Differences between “intact” PTH and 1–84 PTH assays in chronic renal failure and dialysis. Pediatr Nephrol 20:197–199CrossRef Waller S, Ridout D, Cantor T, Rees L (2005) Differences between “intact” PTH and 1–84 PTH assays in chronic renal failure and dialysis. Pediatr Nephrol 20:197–199CrossRef
22.
Zurück zum Zitat Clinical practice guidelines for bone metabolism and disease in chronic kidney disease (2002) Guideline 1. Evaluation of calcium and phosphorous metabolism. NKF K/DOQI guidelines Clinical practice guidelines for bone metabolism and disease in chronic kidney disease (2002) Guideline 1. Evaluation of calcium and phosphorous metabolism. NKF K/DOQI guidelines
23.
Zurück zum Zitat Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence of abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855–861CrossRef Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence of abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855–861CrossRef
24.
Zurück zum Zitat Moe SM, Chen NX (2003) Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18:969–975CrossRef Moe SM, Chen NX (2003) Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18:969–975CrossRef
25.
Zurück zum Zitat Kuizon BD, Salusky IB (2002) Cell biology of renal osteodystrophy. Pediatr Nephrol 17:777–789CrossRef Kuizon BD, Salusky IB (2002) Cell biology of renal osteodystrophy. Pediatr Nephrol 17:777–789CrossRef
26.
Zurück zum Zitat Amann K, Ritz E, Wiest G, Klaus G, Mall G (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814–1819PubMed Amann K, Ritz E, Wiest G, Klaus G, Mall G (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814–1819PubMed
27.
Zurück zum Zitat Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19:478–484CrossRef Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19:478–484CrossRef
28.
Zurück zum Zitat Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, Couttenye MM, De Broe ME, D’Haese PC (2003) Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant 18:1159–1166CrossRef Spasovski GB, Bervoets AR, Behets GJ, Ivanovski N, Sikole A, Dams G, Couttenye MM, De Broe ME, D’Haese PC (2003) Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transplant 18:1159–1166CrossRef
29.
Zurück zum Zitat Langman CB, Mazur AT, Baron R, Norman ME (1982) 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr 100:815–882CrossRef Langman CB, Mazur AT, Baron R, Norman ME (1982) 25-Hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. J Pediatr 100:815–882CrossRef
30.
Zurück zum Zitat Song Y, Kato S, Fleet JC (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133:374–380CrossRef Song Y, Kato S, Fleet JC (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133:374–380CrossRef
31.
Zurück zum Zitat Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907–914CrossRef Salusky IB, Kuizon BD, Belin TR, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907–914CrossRef
32.
Zurück zum Zitat Logue FC, Fraser WD, O’Reilly DS, Cameron DA, Kelly AJ, Beastall GH (1990) The circadian rhythm of intact parathyroid hormone- (1–84): temporal correlation with prolactin secretion in normal men. J Clin Endocrinol Metab 71:1556–1560CrossRef Logue FC, Fraser WD, O’Reilly DS, Cameron DA, Kelly AJ, Beastall GH (1990) The circadian rhythm of intact parathyroid hormone- (1–84): temporal correlation with prolactin secretion in normal men. J Clin Endocrinol Metab 71:1556–1560CrossRef
33.
Zurück zum Zitat Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O’Reilly DS, Beastall GH, Boyle IT (1998) Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int 8:121–126CrossRef Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O’Reilly DS, Beastall GH, Boyle IT (1998) Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int 8:121–126CrossRef
Metadaten
Titel
Calcium and phosphate balance in adolescents on home nocturnal haemodialysis
verfasst von
Daljit K. Hothi
Elizabeth Harvey
Elizabeth Piva
Laura Keating
Donna Secker
Denis F. Geary
Publikationsdatum
01.06.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 6/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0048-z

Weitere Artikel der Ausgabe 6/2006

Pediatric Nephrology 6/2006 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.